Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response to Yang et al.

× No keyword cloud information.

4 in total

1. Combination therapy with sorafenib and radiofrequency ablation for BCLC stage 0-B1 hepatocellular carcinoma.

Authors: Tian Yang; Han Zhang; Yi-Nan Shen; Meng-Chao Wu; Feng Shen; Myron Schwartz
Journal: Am J Gastroenterol Date: 2015-04 Impact factor: 10.864

2. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.

Authors: Hiroyuki Fukuda; Kazushi Numata; Satoshi Moriya; Yu Shimoyama; Tomohiro Ishii; Akito Nozaki; Masaaki Kondo; Manabu Morimoto; Shin Maeda; Kentaro Sakamaki; Satoshi Morita; Katsuaki Tanaka
Journal: Radiology Date: 2014-04-02 Impact factor: 11.105

3. Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study.

Authors: Xiaobin Feng; Ruocai Xu; Xilin Du; Kefeng Dou; Xiao Qin; Jun Xu; Weidong Jia; Zhiming Wang; Hongzhi Zhao; Shufa Yang; Chenyang Guo; Tianqi Liu; Kuansheng Ma
Journal: Am J Gastroenterol Date: 2014-11-18 Impact factor: 10.864

4. Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors: J M Llovet; C Brú; J Bruix
Journal: Semin Liver Dis Date: 1999 Impact factor: 6.115

4 in total